Development of an Intracellular Quantitative Assay to Measure Compound Binding Kinetics | |||||
Thu1 Jul09:10am(20 mins)
|
Charles Lay | ||||
Session : Drugging your target | |||||
Room: Conference Room |
Potential use of CRISPR in therapeutic applications | |||||
Thu1 Jul10:00am(25 mins)
|
Dr Pinar Akcakaya | ||||
Session : Drugging your target | |||||
Room: Conference Room |
The challenges of a novel target portfolio | |||||
Thu1 Jul10:45am(25 mins)
|
Steve Rees | ||||
Session : Drugging your target | |||||
Room: Conference Room |
Targeting KRAS via inhibition of the KRAS-SOS1 interaction | |||||
Thu1 Jul11:10am(15 mins)
|
Dr Roman Hillig | ||||
Session : Drugging your target | |||||
Room: Conference Room |
Writing and erasing O-GlcNAc from target proteins in cells | |||||
Thu1 Jul11:25am(25 mins)
|
Dr Christina Woo | ||||
Session : Drugging your target | |||||
Room: Conference Room |